MMental health Read More Short bursts of oxygen deprivation could help treat depression: Chinese studyNovember 30, 2025 Brief, controlled bouts of oxygen deprivation – essentially moments of safe suffocation – can alleviate severe depression as…
HHealth Read More Freya Pharma Solutions Rebrands as Arletta PharmaNovember 27, 2025 New name reflects company’s transformation as it advances toward the final phase of Lybrido™’s clinical development The Arletta…
HHealthcare Read More EU Reform Aims to Fast-Track Cancer Drug AccessNovember 10, 2025 At the European Society for Medical Oncology (ESMO) Annual Meeting 2025, held recently in Berlin, experts presented an…
MMedication Read More FDA approves new menopause drug without hormones. Here’s what to know.October 28, 2025 The U.S. Food and Drug Administration has approved Lynkuet, a new daily pill from Bayer that provides a…
GGenetics Read More New Guides: Understanding Dementia Risk, Genetics, Diagnosis in Communities of ColorOctober 14, 2025 Is an Alzheimer’s clinical trial right for you? What does it mean to enroll in an Alzheimer’s clinical…
MMedication Read More Common opioid is not that effective for easing chronic pain, study findsOctober 9, 2025 Tramadol, a potent synthetic opioid, has been widely used to treat moderate to severe pain, but a new…
MMedication Read More FDA rejects Rexulti-Zoloft combo for PTSDSeptember 23, 2025 The FDA rejected Otsuka and Lundbeck’s Rexulti and Zoloft combination treatment for PTSD, months after raising concerns about…
EEconomy Read More Draghi had a plan to save Europe’s economy. We’ve rated it, a year in – POLITICOSeptember 8, 2025 Joint debt: Let’s see Draghi has been a consistent advocate for EU joint borrowing of the kind carried…
HHealthcare Read More Life Bio: epigenetic rejuvenation ‘transcends organs’August 26, 2025 Longevity biotech presents data demonstrating therapeutic impact of partial epigenetic reprogramming across multiple biological systems. Today at the…
HHealth Read More Alzheimer’s Med Continues to Deliver Benefit at 3 YearsAugust 21, 2025 Data from the TRAILBLAZER-ALZ 2 long-term extension (LTE) study demonstrated that donanemab (Kisunla, Eli Lilly and Company) continues…
HHealth Read More ADHD Meds Offer Benefits Far Beyond Core Symptom ReliefAugust 20, 2025 Attention-deficit/hyperactivity disorder (ADHD) medications appeared to reduce the risk of suicide, drug misuse, transport incidents, and criminal activity,…